{ "id": "RL32917", "type": "CRS Report", "typeId": "REPORT", "number": "RL32917", "active": false, "source": "University of North Texas Libraries Government Documents Department", "versions": [ { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc815666/", "id": "RL32917_2007Aug03", "date": "2007-08-03", "retrieved": "2016-03-19T13:57:26", "title": "Bioterrorism Countermeasure Development: Issues in Patents and Homeland Security", "summary": null, "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20070803_RL32917_8c757b70f9842d1272d1ebf8f108737b2e284a78.pdf" }, { "format": "HTML", "filename": "files/20070803_RL32917_8c757b70f9842d1272d1ebf8f108737b2e284a78.html" } ], "topics": [] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc822111/", "id": "RL32917_2006Nov27", "date": "2006-11-27", "retrieved": "2016-03-19T13:57:26", "title": "Bioterrorism Countermeasure Development: Issues in Patents and Homeland Security", "summary": null, "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20061127_RL32917_1e34170507aa6dbd7ccef743e1e2e34fd6e76422.pdf" }, { "format": "HTML", "filename": "files/20061127_RL32917_1e34170507aa6dbd7ccef743e1e2e34fd6e76422.html" } ], "topics": [] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metacrs8474/", "id": "RL32917 2006-01-17", "date": "2006-01-17", "retrieved": "2006-03-20T09:59:16", "title": "Bioterrorism Countermeasure Development: Issues in Patents and Homeland Security", "summary": "Congressional interest in the development of bioterrorism countermeasures remains strong, even after passage of legislation establishing Project BioShield. In the 109th Congress, several bills have been introduced, including S. 3, the Protecting America in the War on Terror Act, S. 975, the Project Bioshield II Act, and S. 1873, the Biodefense and Pandemic Vaccine and Drug Development Act, that would generate additional incentives for the creation of new technologies to counteract potential biological threats. These bills propose reforms to current policies and practices associated with intellectual property, particularly patents, and the marketing of pharmaceuticals and related products.", "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20060117_RL32917_5c34abe5fe39e9df14954c624a2e28dd71bd928f.pdf" }, { "format": "HTML", "filename": "files/20060117_RL32917_5c34abe5fe39e9df14954c624a2e28dd71bd928f.html" } ], "topics": [ { "source": "LIV", "id": "Defense policy", "name": "Defense policy" }, { "source": "LIV", "id": "Biological weapons", "name": "Biological weapons" }, { "source": "LIV", "id": "Patent law and legislation", "name": "Patent law and legislation" }, { "source": "LIV", "id": "Counterterrorism", "name": "Counterterrorism" }, { "source": "LIV", "id": "Intellectual property", "name": "Intellectual property" }, { "source": "LIV", "id": "Weapons systems", "name": "Weapons systems" } ] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metacrs6196/", "id": "RL32917 2005-05-06", "date": "2005-05-06", "retrieved": "2005-06-11T05:11:46", "title": "Bioterrorism Countermeasure Development: Issues in Patents and Homeland Security", "summary": "In the 109th Congress, several bills have been introduced, including S. 3, the Protecting America in the War on Terror Act, and S. 975, the Project Bioshield II Act, that would generate additional incentives for the creation of new technologies to counteract potential biological threats. These bills propose reforms to current policies and practices associated with intellectual property, particularly patents, and the marketing of pharmaceuticals and related products. This report includes patents and innovation, the role of patents in pharmaceutical/biomedical R&D, legislative developments and proposals for change.", "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20050506_RL32917_b662f763c0ef452c9e6f8d546a10cbf8f1a8ec02.pdf" }, { "format": "HTML", "filename": "files/20050506_RL32917_b662f763c0ef452c9e6f8d546a10cbf8f1a8ec02.html" } ], "topics": [ { "source": "LIV", "id": "Defense policy", "name": "Defense policy" }, { "source": "LIV", "id": "Biological weapons", "name": "Biological weapons" }, { "source": "LIV", "id": "Patent law and legislation", "name": "Patent law and legislation" }, { "source": "LIV", "id": "Counterterrorism", "name": "Counterterrorism" }, { "source": "LIV", "id": "Intellectual property", "name": "Intellectual property" }, { "source": "LIV", "id": "Weapons systems", "name": "Weapons systems" } ] } ], "topics": [ "American Law", "Economic Policy", "Health Policy" ] }